Literature DB >> 19073177

Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro.

Hisashi Ideno1, Rieko Takanabe, Akemi Shimada, Kazuhiko Imaizumi, Ryoko Araki, Masumi Abe, Akira Nifuji.   

Abstract

Protein related to DAN and cerberus (PRDC) is a secreted protein characterized by a cysteine knot structure, which binds bone morphogenetic proteins (BMPs) and thereby inhibits their binding to BMP receptors. As an extracellular BMP antagonist, PRDC may play critical roles in osteogenesis; however, its expression and function in osteoblastic differentiation have not been determined. Here, we investigated whether PRDC is expressed in osteoblasts and whether it regulates osteogenesis in vitro. PRDC mRNA was found to be expressed in the pre-osteoblasts of embryonic day 18.5 (E18.5) mouse calvariae. PRDC mRNA expression was elevated by treatment with BMP-2 in osteoblastic cells isolated from E18.5 calvariae (pOB cells). Forced expression of PRDC using adenovirus did not affect cell numbers, whereas it suppressed exogenous BMP activity and endogenous levels of phosphorylated Smad1/5/8 protein. Furthermore, PRDC inhibited the expression of bone marker genes and bone-like mineralized matrix deposition in pOB cells. In contrast, the reduction of PRDC expression by siRNA elevated alkaline phosphatase activity, increased endogenous levels of phosphorylated Smad1/5/8 protein, and promoted bone-like mineralized matrix deposition in pOB cells. These results suggest that PRDC expression in osteoblasts suppresses differentiation and that reduction of PRDC expression promotes osteogenesis in vitro. PRDC is accordingly identified as a potential novel therapeutic target for the regulation of bone formation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073177     DOI: 10.1016/j.yexcr.2008.11.019

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  23 in total

1.  Genome-wide association meta-analyses identified 1q43 and 2q32.2 for hip Ward's triangle areal bone mineral density.

Authors:  Yu-Fang Pei; Wen-Zhu Hu; Rong Hai; Xiu-Yan Wang; Shu Ran; Yong Lin; Hui Shen; Qing Tian; Shu-Feng Lei; Yong-Hong Zhang; Christopher J Papasian; Hong-Wen Deng; Lei Zhang
Journal:  Bone       Date:  2016-07-07       Impact factor: 4.398

Review 2.  Systems genetics: a novel approach to dissect the genetic basis of osteoporosis.

Authors:  Charles R Farber
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

3.  Expression and purification of recombinant protein related to DAN and cerberus (PRDC).

Authors:  Chandramohan Kattamuri; David M Luedeke; Thomas B Thompson
Journal:  Protein Expr Purif       Date:  2012-02-20       Impact factor: 1.650

4.  Efficient expansion of mouse primary tenocytes using a novel collagen gel culture method.

Authors:  Akemi Shimada; Satoshi Wada; Kouji Inoue; Hisashi Ideno; Taichi Kamiunten; Koichiro Komatsu; Akira Kudo; Yoshiki Nakamura; Tetsuji Sato; Kazuhisa Nakashima; Akira Nifuji
Journal:  Histochem Cell Biol       Date:  2014-02-11       Impact factor: 4.304

Review 5.  Agonists and Antagonists of TGF-β Family Ligands.

Authors:  Chenbei Chang
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

6.  Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2.

Authors:  Carrie M Nielson; Ching-Ti Liu; Albert V Smith; Cheryl L Ackert-Bicknell; Sjur Reppe; Johanna Jakobsdottir; Christina Wassel; Thomas C Register; Ling Oei; Nerea Alonso; Edwin H Oei; Neeta Parimi; Elizabeth J Samelson; Mike A Nalls; Joseph Zmuda; Thomas Lang; Mary Bouxsein; Jeanne Latourelle; Melina Claussnitzer; Kristin Siggeirsdottir; Priya Srikanth; Erik Lorentzen; Liesbeth Vandenput; Carl Langefeld; Laura Raffield; Greg Terry; Amanda J Cox; Matthew A Allison; Michael H Criqui; Don Bowden; M Arfan Ikram; Dan Mellström; Magnus K Karlsson; John Carr; Matthew Budoff; Caroline Phillips; L Adrienne Cupples; Wen-Chi Chou; Richard H Myers; Stuart H Ralston; Kaare M Gautvik; Peggy M Cawthon; Steven Cummings; David Karasik; Fernando Rivadeneira; Vilmundur Gudnason; Eric S Orwoll; Tamara B Harris; Claes Ohlsson; Douglas P Kiel; Yi-Hsiang Hsu
Journal:  J Bone Miner Res       Date:  2016-09-06       Impact factor: 6.741

Review 7.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

8.  BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction.

Authors:  Lehanna N Sanders; John A Schoenhard; Mohamed A Saleh; Amrita Mukherjee; Sergey Ryzhov; William G McMaster; Kristof Nolan; Richard J Gumina; Thomas B Thompson; Mark A Magnuson; David G Harrison; Antonis K Hatzopoulos
Journal:  Circ Res       Date:  2016-06-09       Impact factor: 17.367

9.  Gremlin 2 promotes differentiation of embryonic stem cells to atrial fate by activation of the JNK signaling pathway.

Authors:  Vineeta Tanwar; Jeffery B Bylund; Jianyong Hu; Jingbo Yan; Joel M Walthall; Amrita Mukherjee; William H Heaton; Wen-Der Wang; Franck Potet; Meena Rai; Sabina Kupershmidt; Ela W Knapik; Antonis K Hatzopoulos
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

10.  The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors.

Authors:  Peggy Benisch; Tatjana Schilling; Ludger Klein-Hitpass; Sönke P Frey; Lothar Seefried; Nadja Raaijmakers; Melanie Krug; Martina Regensburger; Sabine Zeck; Thorsten Schinke; Michael Amling; Regina Ebert; Franz Jakob
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.